Showing results (41-50 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|August 26, 2010
Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective studyAlan Winston, Gerd Fätkenheuer, Jose Arribas, et al.
HIV Clinical Trials|October 27, 2010
Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad® efficacy and safety (SMiLES)José A Vazquez, Lauren L Patton, Joel B Epstein, et al.
HIV Clinical Trials|October 27, 2010
Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trialPartha Sardar, Ayan Jha, Deeptarka Roy, et al.
HIV Clinical Trials|June 3, 2009
Determinants of participation in HIV clinical trials: the importance of patients' trust in their providerElizabeth R Volkmann, Deon Claiborne, Judith S Currier
HIV Clinical Trials|September 3, 2009
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individualsLuigia Elzi, Gilbert Kaufmann, Rainer Weber, et al.
HIV Clinical Trials|May 17, 2015
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trialCynthia Firnhaber, Laura M Smeaton, Beatriz Grinsztejn, et al.
HIV Clinical Trials|May 23, 2015
Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054)Benoit Trottier, Chrissi Galanakis, Danièle Longpré, et al.
HIV Clinical Trials|June 10, 2015
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitopeEmanuele Focà, Maria Luisa Iaria, Francesca Caccuri, et al.
HIV Clinical Trials|December 26, 2002
Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?Daniel González de Requena, Marina Núñez, Oscar Gallego, et al.
HIV Clinical Trials|December 26, 2002
Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participantsXimena Burbano, Maria Jose Miguez-Burbano, Kathryn McCollister, et al.
Pageof 68